rs150731568

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_001130438.3(SPTAN1):​c.2880G>A​(p.Val960Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00026 in 1,614,044 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00093 ( 0 hom., cov: 30)
Exomes 𝑓: 0.00019 ( 2 hom. )

Consequence

SPTAN1
NM_001130438.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 2.45

Publications

0 publications found
Variant links:
Genes affected
SPTAN1 (HGNC:11273): (spectrin alpha, non-erythrocytic 1) Spectrins are a family of filamentous cytoskeletal proteins that function as essential scaffold proteins that stabilize the plasma membrane and organize intracellular organelles. Spectrins are composed of alpha and beta dimers that associate to form tetramers linked in a head-to-head arrangement. This gene encodes an alpha spectrin that is specifically expressed in nonerythrocytic cells. The encoded protein has been implicated in other cellular functions including DNA repair and cell cycle regulation. Mutations in this gene are the cause of early infantile epileptic encephalopathy-5. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010]
SPTAN1 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 5
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, G2P, Ambry Genetics
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neuronopathy, distal hereditary motor, autosomal dominant 11
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary spastic paraplegia
    Inheritance: AR Classification: LIMITED Submitted by: PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.4).
BP6
Variant 9-128588817-G-A is Benign according to our data. Variant chr9-128588817-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 139281.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.45 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000933 (142/152216) while in subpopulation AFR AF = 0.00301 (125/41538). AF 95% confidence interval is 0.00258. There are 0 homozygotes in GnomAd4. There are 68 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High AC in GnomAd4 at 142 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001130438.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPTAN1
NM_001130438.3
MANE Select
c.2880G>Ap.Val960Val
synonymous
Exon 21 of 57NP_001123910.1Q13813-2
SPTAN1
NM_001375318.1
c.2916G>Ap.Val972Val
synonymous
Exon 22 of 59NP_001362247.1
SPTAN1
NM_001375310.1
c.2880G>Ap.Val960Val
synonymous
Exon 21 of 58NP_001362239.1A0A994J6W3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPTAN1
ENST00000372739.7
TSL:1 MANE Select
c.2880G>Ap.Val960Val
synonymous
Exon 21 of 57ENSP00000361824.4Q13813-2
SPTAN1
ENST00000372731.8
TSL:1
c.2880G>Ap.Val960Val
synonymous
Exon 21 of 56ENSP00000361816.4Q13813-1
SPTAN1
ENST00000358161.9
TSL:1
c.2880G>Ap.Val960Val
synonymous
Exon 21 of 55ENSP00000350882.6Q13813-3

Frequencies

GnomAD3 genomes
AF:
0.000934
AC:
142
AN:
152098
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00302
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.000958
GnomAD2 exomes
AF:
0.000330
AC:
83
AN:
251382
AF XY:
0.000302
show subpopulations
Gnomad AFR exome
AF:
0.00308
Gnomad AMR exome
AF:
0.000434
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000132
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000190
AC:
278
AN:
1461828
Hom.:
2
Cov.:
31
AF XY:
0.000194
AC XY:
141
AN XY:
727208
show subpopulations
African (AFR)
AF:
0.00442
AC:
148
AN:
33480
American (AMR)
AF:
0.000537
AC:
24
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53370
Middle Eastern (MID)
AF:
0.00260
AC:
15
AN:
5760
European-Non Finnish (NFE)
AF:
0.0000441
AC:
49
AN:
1112008
Other (OTH)
AF:
0.000646
AC:
39
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
18
37
55
74
92
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000933
AC:
142
AN:
152216
Hom.:
0
Cov.:
30
AF XY:
0.000914
AC XY:
68
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.00301
AC:
125
AN:
41538
American (AMR)
AF:
0.000392
AC:
6
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10596
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68012
Other (OTH)
AF:
0.000948
AC:
2
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000574
Hom.:
0
Bravo
AF:
0.00121
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Developmental and epileptic encephalopathy (1)
-
-
1
Developmental and epileptic encephalopathy, 5 (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.40
CADD
Benign
8.9
DANN
Benign
0.70
PhyloP100
2.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150731568; hg19: chr9-131351096; API